Publications found:
27,881
Sort by:
Assessment of the Japan Generics Industry
US$ 800.00
Executive
While Japan is the second largest pharma market globally, it has a very low penetration rate of generic drugs. The country’s government has set an ambitious goal to enhance the generic...
March 2012
25 pages
Assessment of the Japanese Retail Sector
US$ 800.00
Executive
Due to its large population and an annual GDP per head of greater than USD 43,000, Japan’s retail industry is globally the third-largest, next only to the US and China. The Japane...
March 2012
25 pages
JAPAN DOMESTIC PHARMA- Competitive Landscape of Leading Therapy Classes - UPDATE
US$ 600.00
In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.
March 2012
27 pages
ROCHE - CHUGAI, RoActemra monotherapy Superior to Humira: ADACTA Study
US$ 90.00
In a Ph IV ADACTA monotherapy study, RoActema has shown superior improvement ... the biologic RA market (~ $10B). The data should support Roche’s sNDA for 1st line approval in the US (submitted in December ... in EU where Actemra is already approved in first line, Roche will file for a label change based on this data.
March 2012
2 pages
Analyzing the Tobacco Industry in Japan
US$ 320.00
... . Aruvians Rsearch analyzes the Japanese tobacco industry in its research offering Analyzing the Tobacco Industry in Japan. The report is an in-depth profile of the tobacco industry in Japan as well as the ...
March 2012
75 pages
DIY, Home Improvement and Garden Centres in Japan
US$ 990.00
... positive current value growth in DIY, home improvement and garden centres in 2010 and 2011. Euromonitor International's DIY, Home Improvement and Garden Centres in Japan report offers insight into key ... . Why buy this report? Get a detailed picture of the DIY, Home Improvement and Garden Centres market; Pinpoint growth sectors and identify factors driving ...
February 2012
38 pages
Furniture and Furnishings Stores in Japan
US$ 990.00
... market. However, there is strong demand for... Euromonitor International's Furniture and Furnishings Stores in Japan report offers insight into key trends and developments driving ... , discounters, convenience stores, mixed retailers, health and beauty retailers, clothing and footwear retailers, furniture and furnishing stores, DIY and hardware stores, durable goods ...
February 2012
32 pages
Japan- Pharma Fact Sheet
US$ 400.00
Looking at the great deal of business interest in the Japan Pharmaceutical space, we have recently published a report on Japan Pharma - "Japan Pharma - Factsheet". The 10 page report has som...
February 2012
8 pages
DAIICHI SANKYO - Growth Story Remains Intact!
US$ 90.00
... rating on Daiichi Sankyo (DS) while revising down 12-months TP to ¥1,850 on account of incorporating likely impact of Ranbaxy settlement cost and tax reforms in Japan. Going forward ...
February 2012
2 pages
Future Japanese Tumor Marker Testing Market Outlook
US$ 5,360.00
Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
February 2012
590 pages
Future Japanese Nucleic Acid Testing Market Outlook
US$ 6,000.00
Highlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
February 2012
850 pages
Future Japanese Microbiology Testing Market Outlook
US$ 6,240.00
Highlights Comprehensive 976-page analysis of the Japanese microbiology testing market. Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
976 pages
Future Japanese Transfusion Diagnostic Testing Market Outlook
US$ 5,440.00
... next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi- ...
February 2012
426 pages
Camcorders in Japan
US$ 990.00
... , camcorders were increasingly popular amongst consumers who enjoy taking short videos to post on online media sites such... Euromonitor International's Camcorders in Japan report ... is set to change. Product coverage: Analogue Camcorders, Analogue Cameras, Digital Camcorders, Digital Cameras, E-Readers, Feature Phones, HD Camcorders, Other Portable Media Players, Portable ...
February 2012
27 pages
Cameras in Japan
US$ 990.00
... , the value performance of digital cameras was adversely impacted, with a current value decline of 2% in 2010. Euromonitor International's Cameras in Japan report offers a comprehensive guide ... market is set to change. Product coverage: Analogue Camcorders, Analogue Cameras, Digital Camcorders, Digital Cameras, E-Readers, Feature Phones, HD Camcorders, Other Portable Media ...
February 2012
20 pages
Portable Media Players in Japan
US$ 990.00
... other consumer electronics devices, portable media players declined by 6% in current value terms to reach ¥148.8 billion in 2010. Euromonitor International's Portable Media Players in Japan report offers a comprehensive guide to the size and shape of the in-home, portable and in-car consumer electronics ...
February 2012
27 pages
Japan Generics Market Analysis
US$ 1,000.00
Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expens...
February 2012
55 pages
